Psoriasis Completed Phase 2 Trials for Calcitriol (DB00136)

Also known as: PSORIASIS / Psoriasis unspecified / Psoriasis, unspecified

IndicationStatusPhase
DBCOND0013339 (Psoriasis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00763555Efficacy and Safety Study of CD 2027 Spray in Subjects With Plaque-type PsoriasisTreatment